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Background
Angiogenesis, the formation of new vessels from pre-exist-
ing ones, is essential for tumour growth and metastasis.
Endothelial cells play a central role in this process: they
drive blood vessel formation in response to signals from
the local environment, by a mechanism that is integrin-
dependent. We are particularly interested in understand-
ing what role avb3-integrin plays in governing tumour
angiogenesis.
avb3-integrin seemingly poses an ideal anti-angiogenic
target. Its expression is vastly up-regulated in neo-angio-
genic vessels, while its expression in quiescent vasculature
is minimal. However, anti-angiogenic therapy targeting
avb3-integrin has proven somewhat disappointing. In part
this likely relates to the fact that avb3-integrin is not
expressed solely by endothelial cells, but across a wide
range of cell types that each contribute to angiogenesis.
The aim of the research we present here is to elucidate the
role of avb3-integrin in tumour growth and angiogenesis
as it is expressed specifically by endothelial cells.
Methods
We have crossed b3-integrin floxed animals to two Cre
transgenic models to delete b3-integrin specifically in
endothelial cells. In Pdgfb.Creert2 transgenic mice, b3-
integrin is deleted in a tamoxifen-inducible fashion in neo-
angiogenic endothelial cells, while in Tie1.Cre transgenic
mice b3-integrin is constitutively deleted in endothelial
cells. In these animals, we have studied angiogenesis via
the ex vivo aortic ring model, and in subcutaneoulsy
grown B16F0 and CMT19T allograft tumours.
Results
In b3-floxed/Pdgfb.Creert2 positive mice treated with
tamoxifen, allograft tumours grow significantly smaller
when compared to their growth in Cre negative littermate
controls. This correlates with decreased microvascular
density observed in Cre-postive compared to Cre-negative
tumour sections. In contrast, constitutive deletion of
endothelial b3-integrin via Tie1.Cre leads to enhanced
tumour angiogenesis. These findings are re-capitulated in
the aortic ring model. VEGF-induced microvessel sprout-
ing is inhibited in b3-floxed/Pdgfb.Creert2 positive mice
compared to Cre-negative littermates. In marked contrast,
sprouting is enhanced in b3-floxed/Tie1.Cre positive mice
compared to b3-floxed/Tie1.Cre negative mice.
Conclusions
These findings strengthen the argument that endotheli-
ally-expressed b3-integrin remains a valid target of anti-
angiogenic tumour therapy. However, taken together,
these data suggest that the timing and length of exposure
to b3-integrin endothelial genetic inhibition impacts on
the angiogenic response. These data highlight the need to
enhance our understanding of the molecular basis of
angiogenesis in order to develop improved therapeutic
treatments.
Financial support
University of East Anglia and the BigC Norfolk Cancer
Charity.
Author details
1University of East Anglia, School of Biological Sciences, Norwich, UK.
2Washington University, St Louis, USA. 3Queen Mary’s University London,
Barts Cancer Institute, London, UK.
Published: 4 April 2013
* Correspondence: stephen.robinson@uea.ac.uk
1University of East Anglia, School of Biological Sciences, Norwich, UK
Full list of author information is available at the end of the article
Steri et al. BMC Proceedings 2013, 7(Suppl 2):O7
http://www.biomedcentral.com/1753-6561/7/S2/O7
© 2013 Steri et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
doi:10.1186/1753-6561-7-S2-O7
Cite this article as: Steri et al.: Acute, but not constitutive, loss of
endothelial b3-integrin inhibits tumour growth and angiogenesis. BMC
Proceedings 2013 7(Suppl 2):O7.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Steri et al. BMC Proceedings 2013, 7(Suppl 2):O7
http://www.biomedcentral.com/1753-6561/7/S2/O7
Page 2 of 2
